Scherpereel A - Search Results

1

Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.

Meiller C, Montagne F, Hirsch TZ, Caruso S, de Wolf J, Bayard Q, Assié JB, Meunier L, Blum Y, Quetel L, Gibault L, Pintilie E, Badoual C, Humez S, Galateau-Sallé F, Copin MC, Letouzé E, Scherpereel A, Zucman-Rossi J, Le Pimpec-Barthes F, Jaurand MC, Jean D. Meiller C, et al. Among authors: scherpereel a. Genome Med. 2021 Jul 14;13(1):113. doi: 10.1186/s13073-021-00931-w. Genome Med. 2021. PMID: 34261524 Free PMC article.

2

Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.

Scherpereel A, Grigoriu B, Conti M, Gey T, Grégoire M, Copin MC, Devos P, Chahine B, Porte H, Lassalle P. Scherpereel A, et al. Am J Respir Crit Care Med. 2006 May 15;173(10):1155-60. doi: 10.1164/rccm.200511-1789OC. Epub 2006 Feb 2. Am J Respir Crit Care Med. 2006. PMID: 16456138

3

Endocan expression and relationship with survival in human non-small cell lung cancer.

Grigoriu BD, Depontieu F, Scherpereel A, Gourcerol D, Devos P, Ouatas T, Lafitte JJ, Copin MC, Tonnel AB, Lassalle P. Grigoriu BD, et al. Among authors: scherpereel a. Clin Cancer Res. 2006 Aug 1;12(15):4575-82. doi: 10.1158/1078-0432.CCR-06-0185. Clin Cancer Res. 2006. PMID: 16899604

4

Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma.

Scherpereel A; French Speaking Society for Chest Medicine (SPLF) Experts Group. Scherpereel A, et al. Respir Med. 2007 Jun;101(6):1265-76. doi: 10.1016/j.rmed.2006.10.018. Epub 2006 Nov 29. Respir Med. 2007. PMID: 17137779 Free article.

5

Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.

Grigoriu BD, Scherpereel A, Devos P, Chahine B, Letourneux M, Lebailly P, Grégoire M, Porte H, Copin MC, Lassalle P. Grigoriu BD, et al. Among authors: scherpereel a. Clin Cancer Res. 2007 May 15;13(10):2928-35. doi: 10.1158/1078-0432.CCR-06-2144. Clin Cancer Res. 2007. PMID: 17504993

6

Biomarkers for mesothelioma.

Scherpereel A, Lee YC. Scherpereel A, et al. Curr Opin Pulm Med. 2007 Jul;13(4):339-443. doi: 10.1097/MCP.0b013e32812144bb. Curr Opin Pulm Med. 2007. PMID: 17534183 Review.

7

[Pleural mesothelioma: impact of the staging for the therapeutic strategy].

Greillier L, Scherpereel A, Astoul P; Société de Pneumologie de Langue Francaise sur le Mésothéliome Pleural. Greillier L, et al. Among authors: scherpereel a. Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S146-56. Rev Mal Respir. 2007. PMID: 18235408 Review. French.

8

[New diagnostic markers for malignant pleural mesothelioma].

Grigoriu BD, Grégoire M, Chahine B, Scherpereel A. Grigoriu BD, et al. Among authors: scherpereel a. Bull Cancer. 2008 Feb;95(2):177-84. doi: 10.1684/bdc.2008.0576. Bull Cancer. 2008. PMID: 18304902 Review. French.

9

[Other thoracic cancers. Malignant pleural mesothelioma: biology and diagnosis].

Scherpereel A, Grigoriu BD, Astoul P. Scherpereel A, et al. Rev Mal Respir. 2008 Oct;25(8 Pt 2):3S183-90. Rev Mal Respir. 2008. PMID: 18971844 French.

10

Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment.

Grigoriu BD, Chahine B, Vachani A, Gey T, Conti M, Sterman DH, Marchandise G, Porte H, Albelda SM, Scherpereel A. Grigoriu BD, et al. Among authors: scherpereel a. Am J Respir Crit Care Med. 2009 May 15;179(10):950-4. doi: 10.1164/rccm.200807-1125OC. Epub 2009 Feb 6. Am J Respir Crit Care Med. 2009. PMID: 19201924 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters